Gene · 762
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade. | J Immunol Res | 2022 | 35915657 | PubTator, text mining | PubMed |
| Socioeconomic disadvantage and episodic memory ability in the ABCD sample: Contributions of hippocampal subregion and subfield volumes. | Dev Cogn Neurosci | 2022 | 35907312 | PubTator, text mining | PubMed |
| Future of Digital Assays to Resolve Clinical Heterogeneity of Single Extracellular Vesicles. | ACS Nano | 2022 | 35904433 | PubTator, text mining | PubMed |
| Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention. | Front Digit Health | 2022 | 35899035 | PubTator, text mining | PubMed |
| ZLM-7 Blocks Breast Cancer Progression by Inhibiting MDM2 via Upregulation of 14-3-3 Sigma. | Pharmaceuticals (Basel) | 2022 | 35890172 | PubTator, text mining | PubMed |
| The Cytoprotective, Cytotoxic and Nonprotective Functional Forms of Autophagy Induced by Microtubule Poisons in Tumor Cells-Implications for Autophagy Modulation as a Therapeutic Strategy. | Biomedicines | 2022 | 35884937 | PubTator, text mining | PubMed |
| The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review. | Biomedicines | 2022 | 35884816 | PubTator, text mining | PubMed |
| Engineering CRISPR/Cas13 System against RNA Viruses: From Diagnostics to Therapeutics. | Bioengineering (Basel) | 2022 | 35877342 | PubTator, text mining | PubMed |
| Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma. | Med Sci Monit | 2022 | 35871777 | PubTator, text mining | PubMed |
| Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease. | Acta Neuropathol | 2022 | 35871112 | PubTator, text mining | PubMed |
| Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021). | Acta Pharm Sin B | 2022 | 35865090 | PubTator, text mining | PubMed |
| Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment. | Front Immunol | 2022 | 35860256 | PubTator, text mining | PubMed |
| Molecular View into Preferential Binding of the Factor VII Gla Domain to Phosphatidic Acid. | Biochemistry | 2022 | 35853076 | PubTator, text mining | PubMed |
| Proton export upregulates aerobic glycolysis. | BMC Biol | 2022 | 35840963 | PubTator, text mining | PubMed |
| Impact of carbonic anhydrase 9 gene polymorphism on the progression of colorectal cancer. | J Cancer | 2022 | 35812185 | PubTator, text mining | PubMed |
3D cell cultures, as a surrogate for animal models, enhance the diagnostic value of preclinical in vitro investigations by adding information on the tumour microenvironment: a comparative study of new dual-mode HDAC inhibitors. | Invest New Drugs | 2022 | 35796910 | PubTator, text mining | PubMed |
| Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. | J Hematol Oncol | 2022 | 35794625 | PubTator, text mining | PubMed |
| Genetic dissection of non-syndromic retinitis pigmentosa. | Indian J Ophthalmol | 2022 | 35791117 | PubTator, text mining | PubMed |
| Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles. | Front Pharmacol | 2022 | 35784720 | PubTator, text mining | PubMed |
| Rabbit IgA Hinges That Resist IgA1 Protease Action Provide Options for Improved IgA-Based Therapeutic Agents. | Front Immunol | 2022 | 35784276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/762/papers?page=23